Abnormal functioning of the dorsal lateral prefrontal cortex (DLPF) has been implicated in depression. Repetitive Transcranial Magnetic Stimulation (rTMS) of the DLPF has been successful in treating depression, however, successful translation to routine clinical practice has shown modest results using standard protocols. The present invention provides paradigms, systems, and methods for the targeted, location specific, and pulse-modulated treatment of conditions such as depression, anxiety, OCD, chronic pain syndromes, drug and alcohol addiction, and other conditions through the use of advanced functional MRI (fMRI) or PET/CT, stereotactic neuronavigation, and the performance of cognitive tasks with the maximally efficient delivery of rTMS pulses, which can be varied and precisely targeted, to obtain concurrent activation of targeted brain networks.
